These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6117536)
1. Dysphoric response to neuroleptics as a predictor of treatment outcome with schizophrenics. A comparative study of haloperidol versus mesoridazine. White K; Busk J; Eaton E; Gomez G; Razani J; Sloane RB Int Pharmacopsychiatry; 1981; 16(1):34-8. PubMed ID: 6117536 [TBL] [Abstract][Full Text] [Related]
2. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics. Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133 [TBL] [Abstract][Full Text] [Related]
3. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036 [TBL] [Abstract][Full Text] [Related]
4. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics. Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979 [TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics. Freeman H Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285 [No Abstract] [Full Text] [Related]
8. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison. Deo R; Soni S; Rastogi SC; Levine S; Plant I; Edwards JG; Mitchell M; Chanas A Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470 [TBL] [Abstract][Full Text] [Related]
9. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia. Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317 [TBL] [Abstract][Full Text] [Related]
10. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia. den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG Acta Psychiatr Scand Suppl; 1990; 358():108-10. PubMed ID: 1978468 [TBL] [Abstract][Full Text] [Related]
11. Risperidone in treatment-refractory schizophrenia. Wirshing DA; Marshall BD; Green MF; Mintz J; Marder SR; Wirshing WC Am J Psychiatry; 1999 Sep; 156(9):1374-9. PubMed ID: 10484947 [TBL] [Abstract][Full Text] [Related]
12. Haloperidol does not affect the level of serum-soluble interleukin-2 receptor in drug-free male schizophrenics. Kim CE; Kang DY; Ha KS; Jeong SH; Kim YS Biol Psychiatry; 1995 Dec; 38(12):843-5. PubMed ID: 8750045 [No Abstract] [Full Text] [Related]
13. A double-blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients. Bechelli LP; Ruffino-Netto A; Hetem G Braz J Med Biol Res; 1983 Dec; 16(4):305-11. PubMed ID: 6143579 [TBL] [Abstract][Full Text] [Related]
14. The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia. Klieser E; Strauss WH; Lemmer W Acta Psychiatr Scand Suppl; 1994; 380():68-73. PubMed ID: 8048341 [TBL] [Abstract][Full Text] [Related]
15. A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia. Andersen J; Kørner A; Ostergaard P; Fensbo C; Birket-Smith M; Thiesen S; Hansen NR; Fogh M; Kristensen M; Møller-Nielsen EM Acta Psychiatr Scand Suppl; 1990; 358():104-7. PubMed ID: 1978467 [TBL] [Abstract][Full Text] [Related]
16. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol]. Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338 [TBL] [Abstract][Full Text] [Related]
17. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Arvanitis LA; Miller BG Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900 [TBL] [Abstract][Full Text] [Related]
18. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia. Lindström LH; Wieselgren IM; Struwe G; Kristjansson E; Akselson S; Arthur H; Andersen T; Lindgren S; Norman O; Naimell L Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol. Hwang TJ; Lin SK; Lin HN J Formos Med Assoc; 2001 Dec; 100(12):811-6. PubMed ID: 11802520 [TBL] [Abstract][Full Text] [Related]
20. Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies. Freeman HL Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S11-7. PubMed ID: 9218163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]